Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cardiac rehabilitation in the COVID-19 time. Programs. Results.
Maroto-Montero J, Coello-Cremades M, Martín-Argomanid L, Maroto-de-Pablo M, Gómez-Martínez M, Paredes-Camargo C, de-Pablo-Zarzosa C. Maroto-Montero J, et al. Arch Cardiol Mex. 2021;91(Supl):25-33. doi: 10.24875/ACM.21000186. Arch Cardiol Mex. 2021. PMID: 34968381 Free PMC article. English.
[Analysis of good practices for inhabitant participation in the clinical management units of the Andalusian Health Service (Spain)].
Gómez Martínez ME, Pastor Moreno G, Pérez Corral O, Iriarte de Los Santos MT, Mena Jiménez ÁL, Escudero Espinosa MC, García Romera I, Blanco García MG, Martín Barato A. Gómez Martínez ME, et al. Gac Sanit. 2017 Mar-Apr;31(2):139-144. doi: 10.1016/j.gaceta.2016.06.003. Epub 2016 Sep 14. Gac Sanit. 2017. PMID: 27639499 Free article. Spanish.
[Audit of a hospital internal communication].
Pajares Conde DR, March Cerdá JC, Gómez Martínez ME. Pajares Conde DR, et al. Gac Sanit. 1998 Sep-Oct;12(5):231-8. doi: 10.1016/s0213-9111(98)76477-5. Gac Sanit. 1998. PMID: 9864901 Free article. Spanish.
Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial.
Evering TH, Moser C, Jilg N, Ritz J, Wohl DA, Li JZ, Margolis D, Javan AC, Eron JJ, Currier JS, Daar ES, Smith DM, Hughes MD, Chew KW; ACTIV-2/A5401 Study Team. Evering TH, et al. EClinicalMedicine. 2024 Aug 16;75:102787. doi: 10.1016/j.eclinm.2024.102787. eCollection 2024 Sep. EClinicalMedicine. 2024. PMID: 39252866 Free PMC article.
Profiling and assessing the risks of image- and performance-enhancing drugs use during the COVID-19 lockdown.
De Luca I, Di Carlo F, Burkauskas J, Dores AR, Carvalho IP, Gómez-Martínez MÁ, Szabo A, Fujiwara H, Barbosa CM, Di Nicola M, Mazza M, Sani G, Luciani D, Pettorruso M, di Giannantonio M, Cataldo I, Esposito G, Martinotti G, Zandonai T, Rabin O, Corazza O. De Luca I, et al. Among authors: gomez martinez ma. Front Public Health. 2024 Jun 19;12:1386721. doi: 10.3389/fpubh.2024.1386721. eCollection 2024. Front Public Health. 2024. PMID: 38962770 Free PMC article.
92 results